At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
TRI-fraction Radiotherapy Utilized to Minimize Patient Hospital Trips : A Phase II Trial (TRIUMPH-T Trial)
In Brief
A Phase 2 clinical trial evaluating Accelerated Partial Breast Irradiation, High-Dose Rate Brachytherapy, and 1 other intervention for Ductal Breast Carcinoma In Situ and 6 related conditions. Completed, enrolled 200 participants across 10 sites.
Detailed Summary
This phase II trial studies how well accelerated partial breast irradiation (APBI) using high-dose rate (HDR) brachytherapy works in treating patients with breast cancer that has not spread beyond the breast or the axillary lymph nodes (early-stage) after surgery. Radiation therapy uses a type of energy to kill cancer cells and shrink tumors. Brachytherapy is a type of internal radiation therapy that provides radiation inside the breast to any remaining tumor cells next to the space where the tumor was removed, and is given over a shorter amount of time than standard radiation therapy. Giving accelerated partial breast irradiation (APBI) using high-dose rate (HDR) brachytherapy may reduce the overall time that radiation is delivered to the tumor cells.
Study Details
Timeline
Interventions
Undergo accelerated partial breast irradiation (APBI) using high-dose rate (HDR) brachytherapy
Undergo APBI using HDR brachytherapy
Ancillary studies